- Report
- March 2024
- 145 Pages
Global
From €2877EUR$2,999USD£2,478GBP
- Report
- September 2023
- 115 Pages
Japan
From €2590EUR$2,699USD£2,230GBP
- Report
- November 2023
- 71 Pages
France
From €3358EUR$3,500USD£2,892GBP
- Report
- October 2023
- 80 Pages
Ireland
From €3358EUR$3,500USD£2,892GBP
- Report
- September 2023
- 80 Pages
Israel
From €3358EUR$3,500USD£2,892GBP
- Report
- August 2022
- 116 Pages
Global
From €4318EUR$4,500USD£3,719GBP
- Report
- March 2024
- 57 Pages
From €1434EUR$1,495USD£1,235GBP
Generic Substitution is a market within the pharmaceutical industry that focuses on the production and sale of generic drugs. Generic drugs are copies of brand-name drugs that have the same active ingredients, dosage form, strength, route of administration, safety, efficacy, and intended use. Generic drugs are typically much cheaper than their brand-name counterparts, making them a popular choice for consumers. Generic Substitution is a process in which a generic drug is substituted for a brand-name drug, usually at the request of the patient or physician. This process is regulated by the FDA and is designed to ensure that the generic drug is of the same quality and safety as the brand-name drug.
Some of the major companies in the Generic Substitution market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Show Less Read more